iShares 100 UK Equity Index Fund (UK) D Acc
|AstraZeneca PLC||6.53 %|
|HSBC Holdings PLC||6.34 %|
|GlaxoSmithKline PLC||5.12 %|
|BP PLC||4.73 %|
|British American Tobacco PLC||4.34 %|
|Diageo PLC||4.11 %|
|Royal Dutch Shell PLC Class A||4.04 %|
|Royal Dutch Shell PLC B||3.52 %|
|Unilever PLC||3.06 %|
|Rio Tinto PLC||2.81 %|
|United Kingdom||93.03 %|
|Consumer Defensive||19.01 %|
|Financial Services||17.78 %|
|Basic materials||9.92 %|
|Communication Services||7.64 %|
|Consumer Cyclical||5.74 %|
Kieran Doyle, CFA, Vice President and portfolio manager, is a member of BlackRock's Institutional Index Equity team. Mr. Doyle's service with the firm dates back to 2004, including his years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. At BGI, he was a portfolio manager in the Institutional Index Equity team. Prior to joining BGI, he was with KPMG. Mr. Doyle earned a master's degree in economics and finance from Bristol University in 2000.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.